Tenaya Therapeutics, Inc. Property, Plant and Equipment
Tenaya Therapeutics, Inc. (TNYA) had Property, Plant and Equipment of $2.49 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-05
- 2026-06-30: Property, Plant and Equipment, Net $2.49M.
- 2026-03-31: Property, Plant and Equipment, Net $25.96M.
- 2025-12-31: Property, Plant and Equipment, Net $27.67M.
- 2025-09-30: Property, Plant and Equipment, Net $29.44M.
| Period end | Property, Plant and Equipment, Net |
|---|---|
| 2026-06-30 | $2.49M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $25.96M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $27.67M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $29.44M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $31.29M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $33.36M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $35.86M 10-K · filed 2026-03-11 |
| 2024-09-30 | $37.75M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $39.44M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $41.40M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $43.28M 10-K · filed 2025-03-10 |
| 2023-09-30 | $45.13M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $47.04M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $49.35M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $51.03M 10-K · filed 2024-03-18 |
| 2022-09-30 | $52.19M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $53.01M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $49.38M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $43.02M 10-K · filed 2023-03-08 |
| 2021-09-30 | $30.89M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $24.91M 10-Q · filed 2021-09-08 |
| 2020-12-31 | $17.18M 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |